Very excited about the last #KSchips session today on commercializing tissue chip tech with talks from Geraldine Hamilton (@emulatebio), Thomas Neumann (#Nortis), Uwe Marx (#TissUse), and Jos Joore (@MIMETAS_3D).
Christopher Austin (@ncats_nih_gov): a personalized human-on-a-chip may be feasible, but challenges remain in standardization, cell sourcing, multi-organ media, biomaterials, and throughput/automation. #KSchips
After selling $KITE to $GILD for $11B, Belldegrun and Chang point out its shortfalls and found new company to address them (from @matthewherper): https://t.co/V1oUpPbAgf
CRISPR-Cas9 used to correct hearing loss by editing out Tmc1 mutant allele in deaf mouse model. And the name of that mouse model? Beethoven.
https://t.co/bHekN7OtSv
“Far better an approximate answer to the right question, which is often vague, than an exact answer to the wrong question, which can be made precise.”
-Tukey
“The output of this work is a financial model, typically presented in three parts: the income statement, the balance sheet, and the cash flow statement.”
-Job Taylor “Frizzled to finance…”